Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Therapies: Progressive steps.

× No keyword cloud information.

5 in total

1. Ibudilast in relapsing-remitting multiple sclerosis: a neuroprotectant?

Authors: F Barkhof; H E Hulst; J Drulovic; B M J Uitdehaag; K Matsuda; R Landin
Journal: Neurology Date: 2010-03-03 Impact factor: 9.910

2. Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial.

Authors: Kathleen Hawker; Paul O'Connor; Mark S Freedman; Peter A Calabresi; Jack Antel; Jack Simon; Stephen Hauser; Emmanuelle Waubant; Timothy Vollmer; Hillel Panitch; Jiameng Zhang; Peter Chin; Craig H Smith
Journal: Ann Neurol Date: 2009-10 Impact factor: 10.422

3. Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial.

Authors: Fred Lublin; David H Miller; Mark S Freedman; Bruce A C Cree; Jerry S Wolinsky; Howard Weiner; Catherine Lubetzki; Hans-Peter Hartung; Xavier Montalban; Bernard M J Uitdehaag; Martin Merschhemke; Bingbing Li; Norman Putzki; Fonda C Liu; Dieter A Häring; Ludwig Kappos
Journal: Lancet Date: 2016-01-28 Impact factor: 79.321

4. Drug repurposing: a systematic approach to evaluate candidate oral neuroprotective interventions for secondary progressive multiple sclerosis.

Authors: Hanna M Vesterinen; Peter Connick; Cadi M J Irvine; Emily S Sena; Kieren J Egan; Gary G Carmichael; Afiyah Tariq; Sue Pavitt; Jeremy Chataway; Malcolm R Macleod; Siddharthan Chandran
Journal: PLoS One Date: 2015-04-09 Impact factor: 3.240

5. Development of a Sensitive Outcome for Economical Drug Screening for Progressive Multiple Sclerosis Treatment.

Authors: Peter Kosa; Danish Ghazali; Makoto Tanigawa; Chris Barbour; Irene Cortese; William Kelley; Blake Snyder; Joan Ohayon; Kaylan Fenton; Tanya Lehky; Tianxia Wu; Mark Greenwood; Govind Nair; Bibiana Bielekova
Journal: Front Neurol Date: 2016-08-15 Impact factor: 4.003

5 in total

4 in total

Therapies: Progressive steps.

1. Ibudilast in relapsing-remitting multiple sclerosis: a neuroprotectant?

2. Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial.

3. Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial.

4. Drug repurposing: a systematic approach to evaluate candidate oral neuroprotective interventions for secondary progressive multiple sclerosis.

5. Development of a Sensitive Outcome for Economical Drug Screening for Progressive Multiple Sclerosis Treatment.

1. CNS inflammation and neurodegeneration.

Review 2. Enhancing the Utility of Preclinical Research in Neuropsychiatry Drug Development.

3. Ibudilast attenuates cocaine self-administration and prime- and cue-induced reinstatement of cocaine seeking in rats.

Review 4. Multiple sclerosis and drug discovery: A work of translation.